The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it ...

Impulse Dynamics has secured over $158m in funding aimed at supporting its commercialisation efforts and progressing its ...

Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) Clinical ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two ...

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...

Medline has filed for an initial public offering (IPO) seeking to raise up to $5.37bn, a figure that would leave the medical ...

Pulse Biosciences has partnered with The University of Texas MD Anderson Cancer Centre to investigate the use of the nPulse ...

Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.

Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US FDA for its breast cancer ...

Europe currently has a strong opportunity to become a key global player in agentic artificial intelligence (agentic AI) and ...

Aquapass has secured marketing approval in Israel for the AQUAPASS System, intended for patients experiencing fluid overload.